Home > PJ  > Letters

Return to PJ Online Home Page The Pharmaceutical Journal Vol 266 No 7142 p464-467
April 7, 2001

Letters

  The Media
  NHS
  Community pharmacy
  Parallel imports
  In-store pharmacies
  Medical records
  Labelling
  Access to medicines
  Pricing
  First aid
  Special interest groups
  Emergency contraception
  Hypothyroidism
  The Journal
  SGM


Letters to the Editor

Emergency contraception

OTC domperidone

From Dr S. G. Mann

The reply by Dr Peter Wilson to the letter from Nitin Shah (PJ, March 17, p356) on the use of anti-emetics in emergency hormonal contraception contains a potentially misleading statement relating to domperidone.

Dr Wilson comments that family planning doctors often prescribe domperidone to combat vomiting associated with EHC. He then states: “However there is not a currently licensed OTC indication for domperidone.” We suspect he intended this to convey: “However this is not a currently licensed OTC indication for domperidone.”

Domperidone maleate (Motilium 10) switched from POM to P status in 1998 for the “relief of post-prandial symptoms of fullness, nausea, epigastric bloating and belching that is occasionally accompanied by epigastric discomfort and heartburn”.

We support Dr Wilson's comments on the options open to pharmacists and his suggestion that it may help pharmacists to be aware of how local family planning practitioners manage vomiting associated with EHC.

Stephen G. Mann
Medical Director, Johnson & Johnson MSD


 

Previous Topic (Special interest groups)
Next Topic (Hypothyroidism)
Send your letter to The Editor

Back to Top

©The Pharmaceutical Journal